Arega Pharma
Frank Verbeeck MD is a seasoned professional in the pharmaceutical and clinical research sectors, currently serving as Head of Medical Science and Clinical Development at Zambon since May 2024, where responsibilities include leading medical teams and establishing frameworks for compliant clinical research initiatives. Concurrently, Frank holds the position of Chief Medical Officer at Arega Pharma, focusing on medical affairs and scientific business development since September 2019, and serves as a Non-Executive Board Member for Clinitude, a global clinical CRO specializing in oncology and medical devices. Frank's previous roles include Senior Global Program Clinical Head at Novartis and Vice President of Clinical Development at Galapagos, along with notable management positions at Astellas Pharma Europe and Bristol-Myers Squibb, demonstrating extensive expertise in medical management, clinical operations, and strategic development. Frank obtained a Medical Doctor degree from Vrije Universiteit Brussel, with additional specialization in Clinical Pathology.
This person is not in any teams
Arega Pharma
Arega, group of companies, started its activities in 2019 on the Belgian market as a new full-service healthcare company, active in sales and distribution of medicines, medical devices and selcare products. As the exclusive distributor for Teva Pharmaceuticals Generics and OTC products in Belgium and Luxembourg it ranks in the top 3 of the Belgian generic market. The activities have since then expanded. We engage in developing a line of self-care products and services, where we partner with academic experts. In building our offer we take a holistic approach; we focus on the person, optimize the personal comfort of care and wellbeing, always supported by science. In the event of any side effects, please contact Arega using the report form on our website: https://www.arega.com/reporting-side-effects/ or by emailing safety@arega.com.